ArticleNanomaterials (Basel, Switzerland)2019

In vivo Efficacy and Safety Evaluation of Lactosyl-β-cyclodextrin as a Therapeutic Agent for Hepatomegaly in Niemann-Pick Type C Disease.

Yuki Maeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.